PBFT02

· Passage Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PBFT02, covering 2025-12-31 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes [Phase 1, Phase 2]

See pricing